Cargando…

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes1

AIMS: To compare the efficacy and safety of either continuing or discontinuing rosiglitazone + metformin fixed-dose combination when starting insulin therapy in people with Type 2 diabetes inadequately controlled on oral therapy. METHODS: In this 24-week double-blind study, 324 individuals with Type...

Descripción completa

Detalles Bibliográficos
Autores principales:	Home, P D, Bailey, C J, Donaldson, J, Chen, H, Stewart, M W
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2007
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974817/ https://www.ncbi.nlm.nih.gov/pubmed/17403121 http://dx.doi.org/10.1111/j.1464-5491.2007.02141.x

Ejemplares similares

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)
por: Komajda, Michel, et al.
Publicado: (2008)

Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully
por: Polonsky, William H., et al.
Publicado: (2017)

Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY
Publicado: (2013)

Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT
por: Kahn, Steven E., et al.
Publicado: (2011)

When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury
por: An, Jung Nam, et al.
Publicado: (2021)

Continuous Insulin Infusion: When, Where, and How?
por: Kelly, Janet L.
Publicado: (2014)

Insulin Therapy and Cancer
por: Home, Philip
Publicado: (2013)

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?
por: Home, Philip, et al.
Publicado: (2014)

Consulting to nephrologist when starting continuous renal replacement therapy for acute kidney injury is associated with a survival benefit
por: Lee, Jinwoo, et al.
Publicado: (2023)

Management of Metformin-Associated Lactic Acidosis by Continuous Renal Replacement Therapy
por: Keller, Geoffray, et al.
Publicado: (2011)

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
por: Gordon, J, et al.
Publicado: (2010)

Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2009)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

When to start and when to stop antifibrotic therapies
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2017)

Metformin-associated Lactic Acidosis Successfully Treated with Continuous Renal Replacement Therapy
por: Deepak, Vishal, et al.
Publicado: (2019)

Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2010)

Metformin in combination with rosiglitazone contribute to the increased serum adiponectin levels in people with type 2 diabetes mellitus
por: Nie, Jie-Ming, et al.
Publicado: (2017)

Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
por: DeFronzo, Ralph A., et al.
Publicado: (2010)

Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
por: Lee, J.J.X., et al.
Publicado: (2021)

Comment on: TODAY Study Group. Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY. Diabetes Care 2013;36:1749–1757
por: Baldi, James C., et al.
Publicado: (2013)

Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
por: Li, Feng-fei, et al.
Publicado: (2018)

Machine learning model to predict hypotension after starting continuous renal replacement therapy
por: Kang, Min Woo, et al.
Publicado: (2021)

Rosiglitazone RECORD study: glucose control outcomes at 18 months
por: Home, P D, et al.
Publicado: (2007)

Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: The RealTrend study
por: Raccah, Denis, et al.
Publicado: (2009)

Relationship of glycaemic control and hypoglycaemic episodes to 4‐year cardiovascular outcomes in people with type 2 diabetes starting insulin
por: Freemantle, N., et al.
Publicado: (2015)

When to start antiretroviral therapy: as soon as possible
por: Franco, Ricardo A, et al.
Publicado: (2013)

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study
por: Roussel, Ronan, et al.
Publicado: (2018)

A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen Therapy to Sham Therapy in the Treatment of Diabetic Foot Ulcers
por: Niederauer, Mark Q., et al.
Publicado: (2017)

Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM
por: Guclu, Metin, et al.
Publicado: (2015)

Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis
por: Lu, Yu, et al.
Publicado: (2015)

Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study
por: Home, Philip, et al.
Publicado: (2018)

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
por: Rosenstock, J., et al.
Publicado: (2008)

Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial
por: Deehan, Edward C., et al.
Publicado: (2021)

Comparing the efficacy of continuous and pulsed ultrasound therapies in patients with lateral epicondylitis: A double-blind, randomized, placebo-controlled study
por: Hüseyin Ünver, Hasan, et al.
Publicado: (2021)

Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV-Infected Patients with Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial
por: Glesby, Marshall J., et al.
Publicado: (2013)

When to start aripiprazole therapy in patients with bipolar mania
por: Sayyaparaju, Kiran Kumar, et al.
Publicado: (2014)

Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
por: Franco-Paredes, Carlos, et al.
Publicado: (2017)

Effects of Rosiglitazone with Insulin Combination Therapy on Oxidative Stress and Lipid Profile in Left Ventricular Muscles of Diabetic Rats
por: Kavak, Servet, et al.
Publicado: (2012)

Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin
por: Reid, Laura J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oapos9tmo2e5tfueu4ba8b36i2